Pharma Services February 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Transactions in the Pharma Services industry totaled eleven mergers & acquisitions and three financings during the month of February
• In terms of M&A, the Laboratory Services sector was the most active with 6 transactions; while in terms of financings, the Technology and Information Systems sector was the most active with 2 transactions
• Total disclosed M&A value was $567.1 million, while financings totaled $121.6 million
• The largest disclosed M&A transaction this month was the $522 million acquisition of Citoxlab by Charles River Laboratories International, while the largest financing this month was $100 million raised by Health Catalyst
• M&A and financings in the United States accounted for 36% and 67% of total transactions this month, down 60% and 33%, respectively
• M&A activity this month includes acquisitions by ICON plc., Charles River Laboratories, IQVIA, CBPE Capital, and EPS Holdings
• Crosstree acted as the exclusive financial advisor to MolecularMD on its strategic sale to ICON plc